,afliberceptbevacizumab线:

Jessica Lucchetti1, Lorenzo Angotti2, Alessandro Parisi3

  • 1Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.

PubMed
概括

对于转移性结直肠癌 (mCRC),基于贝瓦齐祖马布的疗法在二线治疗中显示出优异的结果,而不是基于阿弗利塞普的治疗方法. 这在患有KRAS/NRAS和BRAF野生型瘤的患者中尤其明显,证明了改善的生存率和应答率.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K